Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin. The Israel Medical Association journal : IMAJ [Isr Med Assoc J] Journal article
| Advertise on this site. | ||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin. The Israel Medical Association journal : IMAJ [Isr Med Assoc J] Journal article
| |||||||||||||||||||||||||||||||